Published in Bioconjug Chem on December 01, 2009
Gold nanoparticle platforms as drug and biomacromolecule delivery systems. J Control Release (2010) 1.54
Gold nanoparticles: opportunities and challenges in nanomedicine. Expert Opin Drug Deliv (2010) 1.32
Evaluation of cytotoxicity and radiation enhancement using 1.9 nm gold particles: potential application for cancer therapy. Nanotechnology (2010) 1.31
Size matters: gold nanoparticles in targeted cancer drug delivery. Ther Deliv (2012) 1.22
Gold nanoparticles in biology and medicine: recent advances and prospects. Acta Naturae (2011) 1.12
Micelle-encapsulated thiostrepton as an effective nanomedicine for inhibiting tumor growth and for suppressing FOXM1 in human xenografts. Mol Cancer Ther (2011) 1.06
The optical, photothermal, and facile surface chemical properties of gold and silver nanoparticles in biodiagnostics, therapy, and drug delivery. Arch Toxicol (2014) 1.01
The effects of particle size, density and shape on margination of nanoparticles in microcirculation. Nanotechnology (2011) 1.00
Detecting and destroying cancer cells in more than one way with noble metals and different confinement properties on the nanoscale. Acc Chem Res (2012) 0.98
Functionalized Gold Nanoparticles and Their Biomedical Applications. Nanomaterials (Basel) (2011) 0.90
Inducing cancer cell death by targeting its nucleus: solid gold nanospheres versus hollow gold nanocages. Bioconjug Chem (2013) 0.89
Histone deacetylase inhibitors equipped with estrogen receptor modulation activity. J Med Chem (2013) 0.88
Free Rhodium (II) citrate and rhodium (II) citrate magnetic carriers as potential strategies for breast cancer therapy. J Nanobiotechnology (2011) 0.87
Antitumor effect and toxicity of free rhodium (II) citrate and rhodium (II) citrate-loaded maghemite nanoparticles in mice bearing breast cancer. J Nanobiotechnology (2013) 0.87
Antiandrogen gold nanoparticles dual-target and overcome treatment resistance in hormone-insensitive prostate cancer cells. Bioconjug Chem (2012) 0.87
Design, synthesis, and initial biological evaluation of a steroidal anti-estrogen-doxorubicin bioconjugate for targeting estrogen receptor-positive breast cancer cells. Bioconjug Chem (2012) 0.85
Tuning pharmacokinetics and biodistribution of a targeted drug delivery system through incorporation of a passive targeting component. Sci Rep (2014) 0.84
Gold nanoparticles for cancer radiotherapy: a review. Cancer Nanotechnol (2016) 0.81
Nanoconjugation: A Materials Approach to Enhance Epidermal Growth Factor Induced Apoptosis. Biomater Sci (2014) 0.78
Efficient synthesis of diverse heterobifunctionalized clickable oligo(ethylene glycol) linkers: potential applications in bioconjugation and targeted drug delivery. Org Biomol Chem (2013) 0.78
P-glycoprotein-dependent trafficking of nanoparticle-drug conjugates. Small (2014) 0.77
Glutathione-mediated release of Bodipy® from PEG cofunctionalized gold nanoparticles. Int J Nanomedicine (2012) 0.75
Gold Nanoantenna-Mediated Photothermal Drug Delivery from Thermosensitive Liposomes in Breast Cancer. ACS Omega (2016) 0.75
XAV939: from a small inhibitor to a potent drug bioconjugate when delivered by gold nanoparticles. Bioconjug Chem (2014) 0.75
Gold Nanoparticle-Quantum Dot Fluorescent Nanohybrid: Application for Localized Surface Plasmon Resonance-induced Molecular Beacon Ultrasensitive DNA Detection. Nanoscale Res Lett (2016) 0.75
Frizzled7 Antibody-Functionalized Nanoshells Enable Multivalent Binding for Wnt Signaling Inhibition in Triple Negative Breast Cancer Cells. Small (2017) 0.75
Structural modulation of the biological activity of gold nanoparticles functionalized with a carbonic anhydrase inhibitor. Eur Phys J E Soft Matter (2013) 0.75
Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc Natl Acad Sci U S A (2003) 12.17
Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. J Am Chem Soc (2006) 11.99
The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell (1998) 9.96
In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags. Nat Biotechnol (2007) 7.33
Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles. Cancer Lett (2004) 7.12
Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small (2005) 6.90
The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Adv Enzyme Regul (2001) 6.59
Therapeutic nanoparticles for drug delivery in cancer. Clin Cancer Res (2008) 5.67
Cell-specific targeting of nanoparticles by multivalent attachment of small molecules. Nat Biotechnol (2005) 5.19
Triple-negative breast cancer: therapeutic options. Lancet Oncol (2007) 4.80
Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles. Cancer Lett (2005) 4.19
Computationally guided photothermal tumor therapy using long-circulating gold nanorod antennas. Cancer Res (2009) 3.77
PEG-modified gold nanorods with a stealth character for in vivo applications. J Control Release (2006) 3.74
Integration of the extranuclear and nuclear actions of estrogen. Mol Endocrinol (2005) 3.44
Gold nanorod assisted near-infrared plasmonic photothermal therapy (PPTT) of squamous cell carcinoma in mice. Cancer Lett (2008) 3.20
Tamoxifen: a most unlikely pioneering medicine. Nat Rev Drug Discov (2003) 3.07
Influencing receptor-ligand binding mechanisms with multivalent ligand architecture. J Am Chem Soc (2002) 2.94
Multivalent effects of RGD peptides obtained by nanoparticle display. J Med Chem (2006) 2.91
Estrogen receptor in a human cell line (MCF-7) from breast carcinoma. J Biol Chem (1973) 2.58
Gold Nanorods Mediate Tumor Cell Death by Compromising Membrane Integrity. Adv Mater (2007) 2.46
Quantitation of metal content in the silver-assisted growth of gold nanorods. J Phys Chem B (2006) 2.34
Uptake and intracellular fate of surface-modified gold nanoparticles. ACS Nano (2008) 2.25
ERs associate with and regulate the production of caveolin: implications for signaling and cellular actions. Mol Endocrinol (2002) 2.20
Hyperthermic effects of gold nanorods on tumor cells. Nanomedicine (Lond) (2007) 2.20
Tamoxifen and metabolites in MCF7 cells: correlation between binding to estrogen receptor and inhibition of cell growth. Cancer Res (1982) 2.15
The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. Adv Drug Deliv Rev (1995) 2.03
Paclitaxel-functionalized gold nanoparticles. J Am Chem Soc (2007) 1.94
Steroid receptor analyses of nine human breast cancer cell lines. Cancer Res (1978) 1.87
Striatin assembles a membrane signaling complex necessary for rapid, nongenomic activation of endothelial NO synthase by estrogen receptor alpha. Proc Natl Acad Sci U S A (2004) 1.77
Chemoprevention of breast cancer with selective oestrogen-receptor modulators. Nat Rev Cancer (2007) 1.71
Stimulation of c-myc oncogene expression associated with estrogen-induced proliferation of human breast cancer cells. Cancer Res (1987) 1.60
Expression of transforming growth factor alpha and its messenger ribonucleic acid in human breast cancer: its regulation by estrogen and its possible functional significance. Mol Endocrinol (1988) 1.59
Synthesis and grafting of thioctic acid-PEG-folate conjugates onto Au nanoparticles for selective targeting of folate receptor-positive tumor cells. Bioconjug Chem (2006) 1.42
Direct visualization of the human estrogen receptor alpha reveals a role for ligand in the nuclear distribution of the receptor. Mol Biol Cell (1999) 1.40
Biodegradable poly(epsilon -caprolactone) nanoparticles for tumor-targeted delivery of tamoxifen. Int J Pharm (2002) 1.37
Molecular effects of uptake of gold nanoparticles in HeLa cells. Chembiochem (2007) 1.37
Estrogen receptor-dependent and estrogen receptor-independent pathways for tamoxifen and 4-hydroxytamoxifen-induced programmed cell death. J Biol Chem (2002) 1.32
Kinetic analysis of estrogen receptor/ligand interactions. Proc Natl Acad Sci U S A (2002) 1.26
Estrogen receptor-Sp1 complexes mediate estrogen-induced cathepsin D gene expression in MCF-7 human breast cancer cells. J Biol Chem (1994) 1.20
Membrane estrogen receptor-alpha levels in MCF-7 breast cancer cells predict cAMP and proliferation responses. Breast Cancer Res (2004) 1.20
New insights into the metabolism of tamoxifen and its role in the treatment and prevention of breast cancer. Steroids (2007) 1.17
Silver(I) oxide mediated highly selective monotosylation of symmetrical diols. Application to the synthesis of polysubstituted cyclic ethers. Org Lett (2002) 0.98
Significance of immunohistochemical expression of estrogen receptors alpha and beta in squamous cell carcinoma of the esophagus. Clin Cancer Res (2007) 0.95
Regulation of the membrane estrogen receptor-alpha: role of cell density, serum, cell passage number, and estradiol. FASEB J (2002) 0.94
Gold nanoparticles decorated with oligo(ethylene glycol) thiols: protein resistance and colloidal stability. J Phys Chem A (2007) 0.94
Structures and properties of self-assembled monolayers of bistable [2]rotaxanes on Au (111) surfaces from molecular dynamics simulations validated with experiment. J Am Chem Soc (2005) 0.89
Activation of the estrogen-signaling pathway by p21(WAF1/CIP1) in estrogen receptor-negative breast cancer cells. J Natl Cancer Inst (2000) 0.89
Effect of tamoxifen and 2-methoxyestradiol alone and in combination on human breast cancer cell proliferation. J Steroid Biochem Mol Biol (2003) 0.85
Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. J Am Chem Soc (2006) 11.99
Calculated absorption and scattering properties of gold nanoparticles of different size, shape, and composition: applications in biological imaging and biomedicine. J Phys Chem B (2006) 7.53
Chemistry and properties of nanocrystals of different shapes. Chem Rev (2005) 6.83
Noble metals on the nanoscale: optical and photothermal properties and some applications in imaging, sensing, biology, and medicine. Acc Chem Res (2008) 5.42
Surface plasmon resonance scattering and absorption of anti-EGFR antibody conjugated gold nanoparticles in cancer diagnostics: applications in oral cancer. Nano Lett (2005) 4.70
Plasmonic photothermal therapy (PPTT) using gold nanoparticles. Lasers Med Sci (2007) 4.39
Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles. Cancer Lett (2005) 4.19
The golden age: gold nanoparticles for biomedicine. Chem Soc Rev (2011) 3.89
Gold nanoparticles: interesting optical properties and recent applications in cancer diagnostics and therapy. Nanomedicine (Lond) (2007) 3.68
Gold nanorod assisted near-infrared plasmonic photothermal therapy (PPTT) of squamous cell carcinoma in mice. Cancer Lett (2008) 3.20
Gold and silver nanoparticles in sensing and imaging: sensitivity of plasmon response to size, shape, and metal composition. J Phys Chem B (2006) 3.01
Gold nanorods: from synthesis and properties to biological and biomedical applications. Adv Mater (2009) 2.31
Optical properties and ultrafast dynamics of metallic nanocrystals. Annu Rev Phys Chem (2002) 2.30
A reexamination of active and passive tumor targeting by using rod-shaped gold nanocrystals and covalently conjugated peptide ligands. ACS Nano (2010) 2.27
Nuclear targeting of gold nanoparticles in cancer cells induces DNA damage, causing cytokinesis arrest and apoptosis. J Am Chem Soc (2010) 2.22
Cancer cells assemble and align gold nanorods conjugated to antibodies to produce highly enhanced, sharp, and polarized surface Raman spectra: a potential cancer diagnostic marker. Nano Lett (2007) 2.04
Determination of the minimum temperature required for selective photothermal destruction of cancer cells with the use of immunotargeted gold nanoparticles. Photochem Photobiol (2006) 1.92
Plasmon coupling in nanorod assemblies: optical absorption, discrete dipole approximation simulation, and exciton-coupling model. J Phys Chem B (2006) 1.83
Targeted cancer therapy: giving histone deacetylase inhibitors all they need to succeed. Future Med Chem (2012) 1.74
Dependence of the enhanced optical scattering efficiency relative to that of absorption for gold metal nanorods on aspect ratio, size, end-cap shape, and medium refractive index. J Phys Chem B (2005) 1.67
Beating cancer in multiple ways using nanogold. Chem Soc Rev (2011) 1.51
Peptide-conjugated gold nanorods for nuclear targeting. Bioconjug Chem (2007) 1.50
Catalysis with transition metal nanoparticles in colloidal solution: nanoparticle shape dependence and stability. J Phys Chem B (2005) 1.49
The potential use of the enhanced nonlinear properties of gold nanospheres in photothermal cancer therapy. Lasers Surg Med (2007) 1.39
Delivery of molecules into cells using carbon nanoparticles activated by femtosecond laser pulses. Nat Nanotechnol (2010) 1.36
Remote triggered release of doxorubicin in tumors by synergistic application of thermosensitive liposomes and gold nanorods. ACS Nano (2011) 1.25
Applications of gold nanorods for cancer imaging and photothermal therapy. Methods Mol Biol (2010) 1.24
Size matters: gold nanoparticles in targeted cancer drug delivery. Ther Deliv (2012) 1.22
Gold nanoparticles: From nanomedicine to nanosensing. Nanotechnol Sci Appl (2008) 1.21
Ultrafast cooling of photoexcited electrons in gold nanoparticle-thiolated DNA conjugates involves the dissociation of the gold-thiol bond. J Am Chem Soc (2006) 1.13
Non-peptide macrocyclic histone deacetylase inhibitors. J Med Chem (2009) 1.11
Universal scaling of plasmon coupling in metal nanostructures: extension from particle pairs to nanoshells. Nano Lett (2007) 1.09
Synthesis and structure-activity relationship of histone deacetylase (HDAC) inhibitors with triazole-linked cap group. Bioorg Med Chem (2008) 1.09
The assignment of the different infrared continuum absorbance changes observed in the 3000-1800-cm(-1) region during the bacteriorhodopsin photocycle. Biophys J (2004) 1.06
Non-peptide macrocyclic histone deacetylase inhibitors derived from tricyclic ketolide skeleton. J Med Chem (2010) 1.03
Noble metal nanoparticle pairs: effect of medium for enhanced nanosensing. Nano Lett (2008) 1.03
Dark-field light scattering imaging of living cancer cell component from birth through division using bioconjugated gold nanoprobes. J Biomed Opt (2010) 1.02
Observing real-time molecular event dynamics of apoptosis in living cancer cells using nuclear-targeted plasmonically enhanced Raman nanoprobes. ACS Nano (2014) 1.01
The optical, photothermal, and facile surface chemical properties of gold and silver nanoparticles in biodiagnostics, therapy, and drug delivery. Arch Toxicol (2014) 1.01
The most effective gold nanorod size for plasmonic photothermal therapy: theory and in vitro experiments. J Phys Chem B (2014) 1.00
Antimalarial and antileishmanial activities of histone deacetylase inhibitors with triazole-linked cap group. Bioorg Med Chem (2009) 0.99
Synthesis and optical properties of small Au nanorods using a seedless growth technique. Langmuir (2012) 0.98
Macrocyclic histone deacetylase inhibitors. Curr Top Med Chem (2010) 0.98
Detecting and destroying cancer cells in more than one way with noble metals and different confinement properties on the nanoscale. Acc Chem Res (2012) 0.98
Nuclear targeted silver nanospheres perturb the cancer cell cycle differently than those of nanogold. Bioconjug Chem (2011) 0.97
Effect of orientation on plasmonic coupling between gold nanorods. ACS Nano (2009) 0.97
A new catalytically active colloidal platinum nanocatalyst: the multiarmed nanostar single crystal. J Am Chem Soc (2008) 0.97
Comparative study of photothermolysis of cancer cells with nuclear-targeted or cytoplasm-targeted gold nanospheres: continuous wave or pulsed lasers. J Biomed Opt (2010) 0.95
Enhancing colloidal metallic nanocatalysis: sharp edges and corners for solid nanoparticles and cage effect for hollow ones. Acc Chem Res (2013) 0.94
Plasmonic imaging of human oral cancer cell communities during programmed cell death by nuclear-targeting silver nanoparticles. J Am Chem Soc (2011) 0.94
The quenching of CdSe quantum dots photoluminescence by gold nanoparticles in solution. Photochem Photobiol (2002) 0.93
Electrically tunable plasmonic behavior of nanocube-polymer nanomaterials induced by a redox-active electrochromic polymer. ACS Nano (2014) 0.93
Dual targeting of histone deacetylase and topoisomerase II with novel bifunctional inhibitors. J Med Chem (2012) 0.93
Small molecule-gold nanorod conjugates selectively target and induce macrophage cytotoxicity towards breast cancer cells. Small (2012) 0.92
Plasmon field effects on the nonradiative relaxation of hot electrons in an electronically quantized system: CdTe-Au core-shell nanowires. Nano Lett (2008) 0.91
Effect of the dielectric constant of the surrounding medium and the substrate on the surface plasmon resonance spectrum and sensitivity factors of highly symmetric systems: silver nanocubes. J Am Chem Soc (2012) 0.91
Exploiting the nanoparticle plasmon effect: observing drug delivery dynamics in single cells via Raman/fluorescence imaging spectroscopy. ACS Nano (2013) 0.90
Gold nanoframes: very high surface plasmon fields and excellent near-infrared sensors. J Am Chem Soc (2010) 0.90
Selectively targeting prostate cancer with antiandrogen equipped histone deacetylase inhibitors. ACS Chem Biol (2013) 0.90
Comparison of the dynamics of the primary events of bacteriorhodopsin in its trimeric and monomeric states. Biophys J (2002) 0.90
Aggregation and interaction of cationic nanoparticles on bacterial surfaces. J Am Chem Soc (2012) 0.90
Probing the unique dehydration-induced structural modifications in cancer cell DNA using surface enhanced Raman spectroscopy. J Am Chem Soc (2013) 0.89
Effect of catalysis on the stability of metallic nanoparticles: Suzuki reaction catalyzed by PVP-palladium nanoparticles. J Am Chem Soc (2003) 0.89
Inducing cancer cell death by targeting its nucleus: solid gold nanospheres versus hollow gold nanocages. Bioconjug Chem (2013) 0.89
Enhanced photoassisted water electrolysis using vertically oriented anodically fabricated Ti-Nb-Zr-O mixed oxide nanotube arrays. ACS Nano (2010) 0.88
Real-time molecular imaging throughout the entire cell cycle by targeted plasmonic-enhanced Rayleigh/Raman spectroscopy. Nano Lett (2012) 0.88
Histone deacetylase inhibitors equipped with estrogen receptor modulation activity. J Med Chem (2013) 0.88
Gold nanoparticles: catalyst for the oxidation of NADH to NAD(+). J Photochem Photobiol B (2005) 0.88
3-Hydroxypyridin-2-thione as novel zinc binding group for selective histone deacetylase inhibition. J Med Chem (2013) 0.87
Antiandrogen gold nanoparticles dual-target and overcome treatment resistance in hormone-insensitive prostate cancer cells. Bioconjug Chem (2012) 0.87
A new nanotechnology technique for determining drug efficacy using targeted plasmonically enhanced single cell imaging spectroscopy. J Am Chem Soc (2013) 0.86
Changing catalytic activity during colloidal platinum nanocatalysis due to shape changes: electron-transfer reaction. J Am Chem Soc (2004) 0.86
The role of the native lipids and lattice structure in bacteriorhodopsin protein conformation and stability as studied by temperature-dependent Fourier transform-infrared spectroscopy. J Biol Chem (2002) 0.85
Time-resolved long-lived infrared emission from bacteriorhodopsin during its photocycle. Biophys J (2002) 0.85
Shape- and symmetry-dependent mechanical properties of metallic gold and silver on the nanoscale. Nano Lett (2014) 0.85
Surface-enhanced Raman spectroscopy for real-time monitoring of reactive oxygen species-induced DNA damage and its prevention by platinum nanoparticles. ACS Nano (2013) 0.85
The effect of plasmon field on the coherent lattice phonon oscillation in electron-beam fabricated gold nanoparticle pairs. Nano Lett (2007) 0.85
Gold nanoparticles surface plasmon field effects on the proton pump process of the bacteriorhodopsin photosynthesis. J Am Chem Soc (2009) 0.83
Gold nanoparticle formation from photochemical reduction of Au3+ by continuous excitation in colloidal solutions. A proposed molecular mechanism. J Phys Chem B (2005) 0.83
Gold nanoparticles propulsion from surface fueled by absorption of femtosecond laser pulse at their surface plasmon resonance. J Am Chem Soc (2006) 0.82
Effect of colloidal nanocatalysis on the metallic nanoparticle shape: the Suzuki reaction. Langmuir (2005) 0.82
Surface assembly and plasmonic properties in strongly coupled segmented gold nanorods. Small (2013) 0.82
Direct diazo-transfer reaction on beta-lactam: synthesis and preliminary biological activities of 6-triazolylpenicillanic acids. Bioorg Med Chem (2007) 0.82
Molecular mechanism of the photochemical generation of gold nanoparticles in ethylene glycol: support for the disproportionation mechanism. J Phys Chem B (2006) 0.81
A structure-activity relationship study of the antimalarial and antileishmanial activities of nonpeptide macrocyclic histone deacetylase inhibitors. ChemMedChem (2010) 0.81
Vertically oriented Ti-Pd mixed oxynitride nanotube arrays for enhanced photoelectrochemical water splitting. ACS Nano (2011) 0.80
Size-dependent ultrafast electronic energy relaxation and enhanced fluorescence of copper nanoparticles. J Phys Chem B (2006) 0.80
Synthesis and structure-activity relationship of 3-hydroxypyridine-2-thione-based histone deacetylase inhibitors. J Med Chem (2013) 0.80
Interaction of anthracyclines with iron responsive element mRNAs. Nucleic Acids Res (2008) 0.80
On the use of plasmonic nanoparticle pairs as a plasmon ruler: the dependence of the near-field dipole plasmon coupling on nanoparticle size and shape. J Phys Chem A (2009) 0.79
Ultrafast electron relaxation dynamics in coupled metal nanoparticles in aggregates. J Phys Chem B (2006) 0.79